Literature DB >> 31773669

MicroRNA-15a inhibits inflammatory response and apoptosis after spinal cord injury via targeting STAT3.

W-D Wu1, L-H Wang, N-X Wei, D-H Kong, G Shao, S-R Zhang, Y-S Du.   

Abstract

OBJECTIVE: To clarify the function of microRNA-15a in the spinal cord injury (SCI) and its potential mechanism. PATIENTS AND METHODS: The plasma levels of microRNA-15a and signal transducer and activator of transcription 3 (STAT3) in SCI patients were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The correlation between the expressions of microRNA-15a and STAT3 was analyzed. The in vitro SCI model was established in H2O2-induced C8-D1A and C8B4 cells, and in vivo SCI model was established in mice by hitting T10. The mRNA and protein expressions of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) were detected in the SCI model. The apoptosis was examined by flow cytometry or TUNEL staining, respectively. The motor function of mouse hindlimb was evaluated using the Basso Beattie Bresnahan (BBB) standard scale. The target gene of microRNA-15a was predicted by bioinformatics and further verified by dual-luciferase reporter gene assay. The expression changes of target genes in C8-D1A and C8B4 cells with microRNA-15a overexpression or knockdown were examined by qRT-PCR and Western blot. Finally, rescue experiments were performed to evaluate the regulatory effects of microRNA-15a and STAT3 on cell apoptosis.
RESULTS: MicroRNA-15a was lowly expressed in plasma of SCI patients, while STAT3 was highly expressed with a negative correlation to microRNA-15a. Identically, microRNA-15a was lowly expressed in H2O2-induced C8-D1A and C8B4 cells, and STAT3 was highly expressed. MicroRNA-15a overexpression downregulated mRNA and protein levels of TNF-α and IL-6 in C8-D1A and C8B4 cells. BBB score was markedly low in SCI mice relative to controls. SCI mice injected with microRNA-15a mimics had higher BBB score than those injected with negative control. Besides, SCI mice with microRNA-15a overexpression had downregulated expressions of STAT3, TNF-α, and IL-6 in the impaired spinal cord tissues, as well as lower apoptotic rate. Through bioinformatics, we found binding sites between STAT3 and microRNA-15a. Their binding conditions were further verified by dual-luciferase reporter gene assay. Moreover, STAT3 expression was negatively regulated by microRNA-15a. Finally, rescue experiments showed that STAT3 overexpression could reverse the regulatory effects of microRNA-15a on expressions of TNF-α and IL-6, as well as apoptosis.
CONCLUSIONS: MicroRNA-15a expression decreases in the SCI model, which participates in the process of SCI by regulating inflammatory response and cell apoptosis via targeting STAT3.

Entities:  

Year:  2019        PMID: 31773669      PMCID: PMC7415187          DOI: 10.26355/eurrev_201911_19409

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  26 in total

1.  STAT3 signaling after traumatic brain injury.

Authors:  Anthony A Oliva; Yuan Kang; Juliana Sanchez-Molano; Concepción Furones; Coleen M Atkins
Journal:  J Neurochem       Date:  2012-01-31       Impact factor: 5.372

Review 2.  Traumatic spinal cord injury.

Authors:  Christopher S Ahuja; Jefferson R Wilson; Satoshi Nori; Mark R N Kotter; Claudia Druschel; Armin Curt; Michael G Fehlings
Journal:  Nat Rev Dis Primers       Date:  2017-04-27       Impact factor: 52.329

3.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.

Authors:  Seiji Okada; Masaya Nakamura; Hiroyuki Katoh; Tamaki Miyao; Takuya Shimazaki; Ken Ishii; Junichi Yamane; Akihiko Yoshimura; Yukihide Iwamoto; Yoshiaki Toyama; Hideyuki Okano
Journal:  Nat Med       Date:  2006-06-18       Impact factor: 53.440

4.  Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.

Authors:  Andrea M Griesinger; Rebecca J Josephson; Andrew M Donson; Jean M Mulcahy Levy; Vladimir Amani; Diane K Birks; Lindsey M Hoffman; Steffanie L Furtek; Phillip Reigan; Michael H Handler; Rajeev Vibhakar; Nicholas K Foreman
Journal:  Cancer Immunol Res       Date:  2015-05-12       Impact factor: 11.151

5.  Traumatic spinal cord injury in the United States, 1993-2012.

Authors:  Nitin B Jain; Gregory D Ayers; Emily N Peterson; Mitchel B Harris; Leslie Morse; Kevin C O'Connor; Eric Garshick
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

6.  Blood microRNA-15a Correlates with IL-6, IGF-1 and Acute Cerebral Ischemia.

Authors:  Wen-Jing Lu; Li-Li Zeng; Yang Wang; Yu Zhang; Huai-Bin Liang; Xuan-Qiang Tu; Ji-Rong He; Guo-Yuan Yang
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

7.  The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass.

Authors:  Martine Uittenbogaard; Kristin Kathleen Baxter; Anne Chiaramello
Journal:  ASN Neuro       Date:  2010-05-24       Impact factor: 4.146

8.  S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation.

Authors:  Shiyu Song; Haiyan Min; Mengyuan Niu; Lei Wang; Yongzheng Wu; Bin Zhang; Xiufang Chen; Qiao Liang; Yanting Wen; Yong Wang; Long Yi; Hongwei Wang; Qian Gao
Journal:  EBioMedicine       Date:  2018-10-10       Impact factor: 8.143

9.  The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat.

Authors:  Shaohui Zong; Gaofeng Zeng; Ye Fang; Jinzhen Peng; Yong Tao; Keke Li; Jingmin Zhao
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

10.  Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway.

Authors:  Xiao-Qian Li; Feng-Shou Chen; Wen-Fei Tan; Bo Fang; Zai-Li Zhang; Hong Ma
Journal:  J Neuroinflammation       Date:  2017-10-23       Impact factor: 8.322

View more
  7 in total

1.  miRNA Therapy in Laboratory Models of Acute Spinal Cord Injury in Rodents: A Meta-analysis.

Authors:  Yang Wang; Hanxiao Yi; Yancheng Song
Journal:  Cell Mol Neurobiol       Date:  2022-06-01       Impact factor: 5.046

Review 2.  Quercetin Can Improve Spinal Cord Injury by Regulating the mTOR Signaling Pathway.

Authors:  Xichen Wang; Yuke Fu; Benson O A Botchway; Yufeng Zhang; Yong Zhang; Tian Jin; Xuehong Liu
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

3.  Intravital Assessment of Cells Responses to Conducting Polymer-Coated Carbon Microfibres for Bridging Spinal Cord Injury.

Authors:  Bilal El Waly; Vincent Escarrat; Jimena Perez-Sanchez; Jaspreet Kaur; Florence Pelletier; Jorge Eduardo Collazos-Castro; Franck Debarbieux
Journal:  Cells       Date:  2021-01-05       Impact factor: 6.600

4.  Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.

Authors:  Haoyu Wang; Jing Yuan; Xiaoqian Dang; Zhibin Shi; Wenrui Ban; Dong Ma
Journal:  Cell Biosci       Date:  2021-03-11       Impact factor: 7.133

5.  Targeted inhibition of STAT3 in neural stem cells promotes neuronal differentiation and functional recovery in rats with spinal cord injury.

Authors:  Tingting Li; Xiaoyang Zhao; Jing Duan; Shangbin Cui; Kai Zhu; Yong Wan; Shaoyu Liu; Zhiming Peng; Le Wang
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

6.  MicroRNA-182 improves spinal cord injury in mice by modulating apoptosis and the inflammatory response via IKKβ/NF-κB.

Authors:  Min Fei; Zheng Li; Yuanwu Cao; Chang Jiang; Haodong Lin; Zixian Chen
Journal:  Lab Invest       Date:  2021-05-31       Impact factor: 5.662

Review 7.  MiRNAs as Promising Translational Strategies for Neuronal Repair and Regeneration in Spinal Cord Injury.

Authors:  Serena Silvestro; Emanuela Mazzon
Journal:  Cells       Date:  2022-07-12       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.